Gross margin expanded to 46.4% in 2026Q3, but operating margin of 10.8% and revenue growth of only 1.5% suggest the transformation has not yet translated into meaningful top-line acceleration or overhead leverage.
Koninklijke Philips N.V. (PHG) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 17.73B | 17.83B | 18.02B | 18.17B | 17.83B | 17.16B | 17.31B | 17.15B | 18.12B | 17.78B | 24.52B | 24.24B | 21.39B | 23.33B | 24.79B | 22.58B | 25.42B | 23.19B | 26.39B | 26.84B | 26.98B | 30.37B | 30.3B | 28.99B | 31.85B | 32.4B | 37.97B | 31.55B | 30.29B | 34.31B | 31.92B |
| Revenue Growth % | -0.29% | -1.04% | -0.81% | 1.92% | 3.91% | -0.91% | 0.97% | -5.38% | 1.92% | -27.48% | 1.12% | 13.34% | -8.31% | -5.89% | 9.78% | -11.17% | 9.62% | -12.11% | -1.68% | -0.52% | -11.18% | 0.25% | 4.52% | -8.99% | -1.69% | -14.67% | 20.33% | 4.17% | -11.71% | 7.48% | 2.02% |
| Cost of Goods Sold | 9.5B | 9.78B | 10.25B | 10.72B | 10.63B | 9.99B | 9.4B | 9.2B | 9.57B | 9.6B | 13.9B | 14.39B | 13.19B | 13.64B | 15.38B | 13.93B | 15.87B | 15.11B | 17.92B | 17.65B | 18.68B | 20.56B | 20.14B | 19.52B | 21.93B | 22.85B | 28.77B | 24.57B | 23.99B | 25.83B | 24.61B |
| COGS % of Revenue | - | 54.82% | 56.87% | 59.01% | 59.65% | 58.22% | 54.3% | 53.65% | 52.8% | 53.99% | 56.71% | 59.35% | 61.64% | 58.47% | 62.04% | 61.7% | 62.45% | 65.16% | 67.91% | 65.78% | 69.25% | 67.7% | 66.48% | 67.36% | 68.84% | 70.55% | 75.78% | 77.89% | 79.19% | 75.29% | 77.12% |
| Gross Profit | 8.23B | 8.06B | 7.77B | 7.45B | 7.19B | 7.17B | 7.91B | 7.95B | 8.55B | 8.18B | 10.61B | 9.86B | 8.21B | 9.69B | 9.41B | 8.65B | 9.55B | 8.08B | 8.47B | 9.18B | 8.3B | 9.81B | 10.16B | 9.46B | 9.92B | 9.54B | 9.2B | 6.98B | 6.3B | 8.48B | 7.3B |
| Gross Margin % | 46.43% | 45.18% | 43.13% | 40.99% | 40.35% | 41.78% | 45.7% | 46.35% | 47.2% | 46.01% | 43.29% | 40.65% | 38.36% | 41.53% | 37.96% | 38.3% | 37.55% | 34.84% | 32.09% | 34.22% | 30.75% | 32.3% | 33.52% | 32.64% | 31.16% | 29.45% | 24.22% | 22.11% | 20.81% | 24.71% | 22.88% |
| Gross Profit Growth % | - | 3.67% | 4.36% | 3.53% | 0.36% | -9.4% | -0.45% | -7.07% | 4.56% | -22.92% | 7.67% | 20.11% | -15.3% | 2.97% | 8.81% | -9.42% | 18.16% | -4.58% | -7.8% | 10.71% | -15.44% | -3.41% | 7.33% | -4.64% | 4% | 3.77% | 31.78% | 10.72% | -25.67% | 16.08% | -22.87% |
| Operating Expenses | 6.37B | 6.63B | 7.24B | 7.56B | 8.72B | 6.62B | 6.65B | 6.58B | 6.83B | 6.65B | 8.73B | 8.86B | 7.72B | 7.67B | 8.38B | 7.56B | 7.48B | 7.46B | 8.11B | 7.33B | 7.11B | 8.03B | 8.26B | 8.57B | 9.01B | 9.45B | 4.74B | 5.18B | 5.29B | 6.21B | 6.13B |
| OpEx % of Revenue | - | 37.2% | 40.2% | 41.63% | 48.93% | 38.56% | 38.4% | 38.39% | 37.72% | 37.42% | 35.6% | 36.56% | 36.08% | 32.87% | 33.8% | 33.49% | 29.43% | 32.19% | 30.74% | 27.31% | 26.37% | 26.43% | 27.27% | 29.56% | 28.28% | 29.17% | 12.5% | 16.41% | 17.48% | 18.09% | 19.22% |
| Selling, General & Admin | 4.85B | 4.97B | 5.07B | 5.13B | 5.29B | 4.86B | 4.55B | 4.56B | 5.13B | 4.97B | 6.73B | 7.02B | 5.87B | 6.02B | 6.27B | 6B | 5.98B | 5.89B | 6.51B | 5.84B | 5.68B | 5.93B | 5.85B | 6.06B | 6.43B | 6.27B | 6.28B | 5.57B | 5.48B | 6.34B | 6.29B |
| SG&A % of Revenue | - | 27.87% | 28.12% | 28.25% | 29.69% | 28.31% | 26.29% | 26.59% | 28.32% | 27.98% | 27.46% | 28.97% | 27.45% | 25.82% | 25.28% | 26.58% | 23.53% | 25.41% | 24.67% | 21.77% | 21.05% | 19.52% | 19.3% | 20.89% | 20.18% | 19.35% | 16.53% | 17.64% | 18.1% | 18.47% | 19.69% |
| Research & Development | 1.71B | 1.7B | 1.75B | 1.89B | 2.09B | 1.81B | 1.91B | 1.79B | 1.76B | 1.76B | 2.02B | 1.93B | 1.64B | 1.73B | 1.81B | 1.61B | 1.58B | 1.63B | 1.78B | 1.63B | 1.67B | 2.55B | 2.53B | 2.61B | 3.05B | 3.32B | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | 9.53% | 9.69% | 10.4% | 11.73% | 10.53% | 11.06% | 10.44% | 9.71% | 9.92% | 8.24% | 7.95% | 7.64% | 7.43% | 7.3% | 7.13% | 6.2% | 7.03% | 6.73% | 6.08% | 6.18% | 8.4% | 8.36% | 9.01% | 9.56% | 10.24% | - | - | - | - | - |
| Other Operating Expenses | -1000K | -36M | 429M | 541M | 1.34B | -48M | 183M | 232M | 9M | 21M | 0 | 0 | 211M | -32M | 326M | -50M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -466M | -137.12M | -1.53B | -388.57M | -189.29M | -130M | -151.86M |
| Operating Income | 1.86B | 1.42B | 529M | -115M | -1.53B | 553M | 1.26B | 1.37B | 1.72B | 1.52B | 1.88B | 992M | 486M | 1.99B | 1.03B | -269M | 2.06B | 614M | 54M | 1.85B | 1.18B | 1.78B | 1.61B | 487.53M | 420.26M | -1.37B | 4.29B | 1.76B | 681.28M | 2.23B | 835.61M |
| Operating Margin % | 10.5% | 7.98% | 2.94% | -0.63% | -8.58% | 3.22% | 7.3% | 7.97% | 9.49% | 8.53% | 7.68% | 4.09% | 2.27% | 8.53% | 4.16% | -1.19% | 8.12% | 2.65% | 0.2% | 6.91% | 4.38% | 5.85% | 5.3% | 1.68% | 1.32% | -4.24% | 11.31% | 5.57% | 2.25% | 6.49% | 2.62% |
| Operating Income Growth % | - | 169.19% | 560% | 92.48% | -376.49% | -56.25% | -7.47% | -20.54% | 13.32% | -19.39% | 89.72% | 104.12% | -75.59% | 93.3% | 482.9% | -113.03% | 236.32% | 1037.04% | -97.09% | 56.8% | -33.45% | 10.67% | 229.4% | 16.01% | 130.6% | -131.99% | 144.47% | 157.76% | -69.39% | 166.33% | -51.21% |
| EBITDA | 3.04B | 2.55B | 1.92B | 1.15B | 73M | 1.88B | 2.33B | 2.27B | 2.81B | 2.54B | 3.15B | 2.27B | 1.67B | 3.34B | 2.46B | 1.19B | 3.49B | 2.08B | 1.24B | 2.71B | 2.02B | 3.28B | 3.9B | 2.5B | 2.61B | 1.43B | 6.62B | 3.61B | 2.56B | 3.9B | 2.5B |
| EBITDA Margin % | 17.15% | 14.29% | 10.64% | 6.31% | 0.41% | 10.93% | 13.46% | 13.24% | 15.5% | 14.3% | 12.84% | 9.38% | 7.82% | 14.32% | 9.94% | 5.26% | 13.72% | 8.98% | 4.71% | 10.09% | 7.48% | 10.81% | 12.86% | 8.62% | 8.18% | 4.41% | 17.44% | 11.46% | 8.45% | 11.38% | 7.82% |
| EBITDA Growth % | 33.58% | 32.9% | 67.36% | 1469.86% | -96.11% | -19.52% | 2.69% | -19.16% | 10.46% | -19.28% | 38.54% | 35.86% | -49.91% | 35.61% | 107.5% | -65.96% | 67.4% | 67.44% | -54.05% | 34.22% | -38.59% | -15.72% | 55.96% | -4.13% | 82.46% | -78.42% | 83.14% | 41.16% | -34.42% | 56.46% | -20.37% |
| D&A (Non-Cash Add-back) | 1.18B | 1.13B | 1.39B | 1.26B | 1.6B | 1.32B | 1.07B | 904M | 1.09B | 1.02B | 1.27B | 1.28B | 1.19B | 1.35B | 1.43B | 1.46B | 1.42B | 1.47B | 1.19B | 852.54M | 834.22M | 1.51B | 2.29B | 2.01B | 2.19B | 2.8B | 2.33B | 1.86B | 1.88B | 1.68B | 1.66B |
| EBIT | 1.96B | 1.51B | 460M | -220M | -1.49B | 673M | 1.69B | 1.72B | 1.71B | 1.62B | 1.38B | 782M | 600M | 1.93B | 698M | -366M | 2.29B | 839M | 1.65B | 1.86B | 1.2B | 1.56B | 1.16B | 894.08M | 916.76M | 93.28M | 4.45B | 1.8B | 1.02B | 1.74B | 688.57M |
| Net Interest Income | -222.08M | -223.8M | -257M | -260M | -219M | -146M | -178.98M | -179.08M | -219M | -81M | -421M | -223M | -188M | -330M | -329M | -331M | -121M | -166M | 88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 147.39M | 108.54M | 79M | 46M | 25M | 18M | 14.82M | 30.22M | 51M | 126M | 76M | 98M | 114M | 70M | 106M | 112M | 214M | 225M | 140M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 369.48M | 332.34M | 337M | 306M | 244M | 164M | 193.8M | 209.3M | 264M | 263M | 569M | 467M | 415M | 400M | 352M | 352M | 336M | 391M | 246M | 0 | 0 | 0 | 0 | 439.1M | 5.97B | 4.6B | 0 | 0 | 0 | 0 | 1.58B |
| Other Income/Expense | -538.91M | -242M | -406M | -412M | -202M | -44M | -53M | -119M | -216M | -140M | -75M | -329M | -239M | -194M | -329M | -541M | -131M | -166M | 88M | 2.62B | 28.03M | 1.28B | 666.13M | 204.86M | -3.6B | -1.66B | 5.91B | 390.56M | -103.17M | 213.64M | -714.28M |
| Pretax Income | 1.32B | 1.18B | 123M | -527M | -1.73B | 509M | 1.21B | 1.25B | 1.5B | 1.38B | 1.39B | 623M | 185M | 1.66B | 784M | -509M | 1.94B | 448M | 142M | 4.47B | 1.22B | 1.89B | 1.82B | 692.39M | -3.18B | -3.03B | 10.2B | 2.15B | 578.96M | 1.91B | 439.5M |
| Pretax Margin % | 7.46% | 6.63% | 0.68% | -2.9% | -9.71% | 2.97% | 6.99% | 7.27% | 8.29% | 7.74% | 5.67% | 2.57% | 0.86% | 7.12% | 3.16% | -2.25% | 7.64% | 1.93% | 0.54% | 16.66% | 4.51% | 6.21% | 6.01% | 2.39% | -9.99% | -9.35% | 26.87% | 6.8% | 1.91% | 5.56% | 1.38% |
| Income Tax | 368.45M | 282M | 963M | -73M | -113M | -103M | 212M | 258M | 193M | 349M | 327M | 239M | 26M | 466M | 308M | 283M | 509M | 100M | 256M | 622.77M | 137.14M | 585.95M | 357.77M | -15.09M | 26.68M | -421.47M | 571.77M | 336.89M | 40.93M | 431.82M | 106.06M |
| Effective Tax Rate % | 27.84% | 23.86% | 782.93% | 13.85% | 6.53% | -20.24% | 17.51% | 20.69% | 12.84% | 25.34% | 23.54% | 38.36% | 14.05% | 28.06% | 39.29% | -55.6% | 26.2% | 22.32% | 180.28% | 13.93% | 11.27% | 31.08% | 19.64% | -2.18% | -0.84% | 13.91% | 5.61% | 15.69% | 7.07% | 22.63% | 24.13% |
| Net Income | 956.84M | 895M | -702M | -466M | -1.61B | 3.32B | 1.19B | 1.17B | 1.09B | 1.66B | 1.45B | 645M | 415M | 1.17B | 226M | -1.29B | 1.45B | 410M | -92M | 4.17B | 5.38B | 2.87B | 2.83B | 693.19M | -3.21B | -2.61B | 9.63B | 1.8B | 6.02B | 2.57B | -272.38M |
| Net Margin % | 5.4% | 5.02% | -3.9% | -2.56% | -9.02% | 19.35% | 6.86% | 6.81% | 6.02% | 9.32% | 5.91% | 2.66% | 1.94% | 5.01% | 0.91% | -5.74% | 5.69% | 1.77% | -0.35% | 15.56% | 19.96% | 9.44% | 9.35% | 2.39% | -10.07% | -8.05% | 25.36% | 5.72% | 19.88% | 7.5% | -0.85% |
| Net Income Growth % | 479.9% | 227.49% | -50.64% | 71.02% | -148.45% | 179.61% | 1.71% | 7.06% | -34.22% | 14.43% | 124.5% | 55.42% | -64.5% | 417.26% | 117.45% | -189.56% | 252.68% | 545.65% | -102.2% | -22.45% | 87.81% | 1.14% | 308.86% | 121.6% | -23% | -127.09% | 433.51% | -70.02% | 134.07% | 1044.21% | -121.12% |
| Net Income (Continuing) | 954.82M | 900M | -840M | -454M | -1.62B | 612M | 999M | 989M | 1.31B | 1.03B | 831M | 160M | 221M | 1.03B | -166M | -1.05B | 1.47B | 424M | -95M | 4.61B | 900.89M | 2.88B | 2.58B | 707.48M | -3.21B | -2.61B | 9.63B | 1.81B | 541.44M | 1.22B | 128.56M |
| Discontinued Operations | 0 | -4M | 142M | -10M | 13M | 2.71B | 196M | 183M | 0 | 843M | 660M | 479M | 190M | 138M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 29.49M | 32M | 37M | 33M | 34M | 36M | 31M | 28M | 29M | 24M | 907M | 118M | 101M | 13M | 34M | 34M | 46M | 49M | 46M | 41.84M | 131.08M | 331.81M | 282.53M | 174.69M | 179.16M | 202.3M | 470.62M | 333.91M | 240.45M | 1.08B | 699.02M |
| EPS (Diluted) | 0.97 | 0.93 | -0.75 | -0.49 | -1.68 | 0.64 | 1.23 | 1.20 | 1.09 | 1.64 | 1.46 | 0.66 | 0.42 | 1.19 | 0.23 | -1.27 | 1.44 | 0.41 | -0.09 | 3.58 | 4.27 | 2.15 | 2.07 | 0.51 | -2.36 | -1.91 | 6.79 | 1.32 | 4.26 | 1.88 | -0.19 |
| EPS Growth % | 523.19% | 224% | -53.06% | 70.83% | -362.5% | -47.97% | 2.5% | 10.09% | -33.54% | 12.33% | 121.21% | 57.14% | -64.71% | 417.39% | 118.11% | -188.19% | 251.22% | 573.44% | -102.42% | -16.16% | 98.6% | 3.86% | 305.88% | 121.61% | -23.56% | -128.13% | 414.39% | -69.01% | 126.6% | 1089.47% | -182.61% |
| EPS (Basic) | - | 0.95 | -0.75 | -0.49 | -1.68 | 0.67 | 1.25 | 1.21 | 1.11 | 1.67 | 1.48 | 0.66 | 0.42 | 1.20 | 0.23 | -1.28 | 1.44 | 0.41 | -0.09 | 3.61 | 4.30 | 2.15 | 2.08 | 0.51 | -2.36 | -1.91 | 6.86 | 1.32 | 4.29 | 1.88 | -0.19 |
| Diluted Shares Outstanding | 989.9M | 962.5M | 933.37M | 948.79M | 952.46M | 950.28M | 957.56M | 972.79M | 997.48M | 1.01B | 989.95M | 984.45M | 983.48M | 982.79M | 987.99M | 1.02B | 1.01B | 990.22M | 1.06B | 1.17B | 1.26B | 1.34B | 1.37B | 1.36B | 1.36B | 1.36B | 1.42B | 1.37B | 1.37B | 1.37B | 1.4B |
| Basic Shares Outstanding | 977.55M | 962.37M | 933.37M | 948.79M | 952.46M | 907.46M | 948.26M | 962.2M | 983.77M | 989.96M | 978.47M | 976.41M | 975.46M | 971.07M | 987.99M | 1.02B | 1B | 986.43M | 1.06B | 1.16B | 1.25B | 1.33B | 1.36B | 1.36B | 1.36B | 1.36B | 1.4B | 1.37B | 1.37B | 1.37B | 1.4B |
| Dividend Payout Ratio | - | 36.65% | - | - | - | 17.17% | 0.08% | 43.45% | 36.79% | 23.17% | 22.79% | 46.2% | 70.36% | 23.27% | 112.83% | - | 20.47% | 154.63% | - | - | 9.71% | 17.56% | 16.22% | 66.21% | - | - | 4.16% | 20.04% | 5.4% | 9.72% | - |
Quick answers to the most common questions about buying PHG stock.
For fiscal year 2025, Koninklijke Philips N.V. (PHG) reported total revenue of $17.83B. This represents a 44.1% decline compared to $31.92B in 1996.
Koninklijke Philips N.V. (PHG) is profitable, generating $895.0M in net income for the fiscal year ending 2025 with a net profit margin of 5.0%.
Koninklijke Philips N.V. (PHG) reported an operating income of $1.42B, resulting in an operating profit margin of 8.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Koninklijke Philips N.V. (PHG) generated $8.06B in gross profit for the year, representing a gross profit margin of 45.2%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Litigation and recall overhang
Flat Top Line Masks Mixed Quarterly Momentum
Based on reported quarterly figures, Philips' revenue has hovered around $4.1B to $5.1B over ten quarters, with year-over-year growth in the latest quarter at 1.5%, suggesting the transformation has not yet produced top-line acceleration.
The revenue series shows seasonal peaks in fourth quarters, with 2025Q4 reaching $5.1B, yet underlying growth has oscillated between roughly -4.7% and +1.5%. This pattern suggests the business is stabilizing rather than expanding, and investors should monitor whether order intake, which is not visible on the income statement, confirms a sustainable recovery. Without clear evidence of volume-led growth, the trajectory appears more consistent with market-level softness than with a company-specific inflection.
Gross Margin Recovery Outpaces Operating Conversion
Reported gross margin has recovered from 38.9% in 2024Q4 to 46.4% in 2026Q3, yet operating margin of 10.8% in the same quarter indicates that a substantial share of gross profit is absorbed by operating expenses.
The gross margin improvement appears to reflect better pricing discipline or a mix shift toward higher-value services, though the source of the gain cannot be isolated from the figures provided. The gap between gross and operating margin, consistently around 30 to 36 points, suggests a heavy overhead base that limits the translation of gross gains into earnings. Investors may wish to test whether sustained gross margin expansion can outrun the fixed-cost structure.
Operating Leverage Remains Modest and Uneven
Operating income has ranged from $154M to $816M across the period, with SG&A holding near $1.2B to $1.3B per quarter, indicating that overhead has not scaled down meaningfully as revenue fluctuated.
Because SG&A remains largely flat in absolute terms while revenue moves within a narrow band, operating income is highly sensitive to gross profit swings rather than to structural cost reduction. The 2024Q2 peak of $816M operating income reflects this sensitivity and suggests the earnings base is more volatile than the revenue base. This pattern may indicate limited evidence of durable operating leverage, warranting continued scrutiny of overhead efficiency.
Net Income Volatility Signals Non-Operating Noise
Net income swings from a $335M loss in 2024Q4 to $395M profit in 2025Q4 diverge sharply from operating income trends, based on reported figures suggesting material non-operating or one-time items.
The gap between operating income and net income in several quarters, including 2024Q2 where net income of $451M sits well below operating income of $816M, implies substantial tax, financing, or discontinued-operation effects. Stock-based compensation is modest relative to earnings, so it does not appear to explain the variance. Investors should treat reported EPS with caution until the drivers of these non-operating items are reconciled.
Litigation Overhang Could Cap Margin Recovery
Bears would argue that the recent 46.4% gross margin may not be sustainable given recall-related remediation costs and continued share loss to ResMed in respiratory care, both of which may pressure future pricing and cash flow.
Remediation and litigation provisions are often excluded from adjusted figures yet represent real cash outflows that the reported income statement may only partially reflect. If the Respironics franchise continues to lose share, the revenue ceiling in that segment may be structurally lower, which would weigh on the service revenue that stabilizes margins. Investors should weigh whether the current margin recovery reflects durable improvement or temporary benefits that could reverse.